Ann H. Korzun

1.5k total citations
18 papers, 998 citations indexed

About

Ann H. Korzun is a scholar working on Oncology, Cancer Research and Epidemiology. According to data from OpenAlex, Ann H. Korzun has authored 18 papers receiving a total of 998 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 6 papers in Cancer Research and 4 papers in Epidemiology. Recurrent topics in Ann H. Korzun's work include Cancer Treatment and Pharmacology (9 papers), Breast Cancer Treatment Studies (6 papers) and HER2/EGFR in Cancer Research (3 papers). Ann H. Korzun is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), Breast Cancer Treatment Studies (6 papers) and HER2/EGFR in Cancer Research (3 papers). Ann H. Korzun collaborates with scholars based in United States, France and Canada. Ann H. Korzun's co-authors include Richard Hafner, Michael C. Perry, Robert A. Larsen, William G. Powderly, Jeffrey M. Jacobson, Joseph Wheat, Frederick Hecht, Jack S. Remington, Jean‐Louis Vildé and Diana Antoniskis and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and American Journal of Psychiatry.

In The Last Decade

Ann H. Korzun

18 papers receiving 965 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann H. Korzun United States 13 420 347 227 219 147 18 998
Ming Guan China 22 188 0.4× 160 0.5× 93 0.4× 305 1.4× 106 0.7× 77 1.1k
Sophie Grabar France 26 691 1.6× 356 1.0× 68 0.3× 706 3.2× 127 0.9× 75 2.1k
N. George Liomba Malawi 16 179 0.4× 224 0.6× 113 0.5× 202 0.9× 42 0.3× 24 1.2k
A.B.M. Foot United Kingdom 20 364 0.9× 197 0.6× 46 0.2× 216 1.0× 93 0.6× 34 1.2k
Robert G. Graw United States 18 262 0.6× 845 2.4× 125 0.6× 71 0.3× 17 0.1× 32 1.8k
Akiko Ohta Japan 17 323 0.8× 237 0.7× 36 0.2× 96 0.4× 159 1.1× 39 1.3k
Hans Jürgen Dornbusch Austria 18 426 1.0× 141 0.4× 35 0.2× 375 1.7× 36 0.2× 41 895
I Ocaña Spain 31 934 2.2× 201 0.6× 85 0.4× 1.1k 4.8× 51 0.3× 89 2.4k
Catherine A. Forbes Australia 17 453 1.1× 271 0.8× 38 0.2× 50 0.2× 37 0.3× 32 1.2k
J. L. Ziegler Uganda 10 289 0.7× 345 1.0× 24 0.1× 140 0.6× 16 0.1× 18 962

Countries citing papers authored by Ann H. Korzun

Since Specialization
Citations

This map shows the geographic impact of Ann H. Korzun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann H. Korzun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann H. Korzun more than expected).

Fields of papers citing papers by Ann H. Korzun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann H. Korzun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann H. Korzun. The network helps show where Ann H. Korzun may publish in the future.

Co-authorship network of co-authors of Ann H. Korzun

This figure shows the co-authorship network connecting the top 25 collaborators of Ann H. Korzun. A scholar is included among the top collaborators of Ann H. Korzun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann H. Korzun. Ann H. Korzun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hecht, Frederick, Joseph Wheat, Ann H. Korzun, et al.. (1997). Itraconazole Maintenance Treatment for Histoplasmosis in AIDS: A Prospective, Multicenter Trial. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 16(2). 100–107. 44 indexed citations
2.
Perloff, Michael, Larry Norton, Ann H. Korzun, et al.. (1996). Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study.. Journal of Clinical Oncology. 14(5). 1589–1598. 42 indexed citations
3.
Kiang, David T., B. J. Kennedy, Jerry Younger, et al.. (1995). Alternating chemotherapy regimens for patients with metastatic breast cancer. A pilot study based on tumor marker kinetics. Cancer. 75(3). 826–830. 5 indexed citations
4.
Wheat, Joseph, Richard Hafner, Ann H. Korzun, et al.. (1995). Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. The American Journal of Medicine. 98(4). 336–342. 180 indexed citations
5.
Luft, Benjamin J., Richard Hafner, Ann H. Korzun, et al.. (1993). Toxoplasmic Encephalitis in Patients with the Acquired Immunodeficiency Syndrome. New England Journal of Medicine. 329(14). 995–1000. 293 indexed citations
6.
Dawson, Nancy A., Mary E. Costanza, Ann H. Korzun, et al.. (1991). Trimetrexate in untreated and previously treated patients with metastatic breast cancer: A cancer and leukemia group b study. Medical and Pediatric Oncology. 19(4). 283–288. 11 indexed citations
7.
Oster, Martin W., Richard L. Schilsky, David Faraggi, et al.. (1991). Cytosine arabinoside and cisplatin for advanced breast cancer. A phase II study of the cancer and leukemia group B. Cancer. 68(8). 1696–1698. 7 indexed citations
8.
Schilsky, Richard L., David Faraggi, Ann H. Korzun, et al.. (1991). Phase II study of echinomycin in patients with advanced breast cancer: A report of cancer and leukemia group B protocol 8641. Investigational New Drugs. 9(3). 269–272. 20 indexed citations
9.
Hayes, Daniel F., Ricardo Mesa‐Tejada, Lawrence D. Papsidero, et al.. (1991). Prediction of prognosis in primary breast cancer by detection of a high molecular weight mucin-like antigen using monoclonal antibodies DF3, F36/22, and CU18: a Cancer and Leukemia Group B study.. Journal of Clinical Oncology. 9(7). 1113–1123. 60 indexed citations
10.
Echo, David Van, Ann H. Korzun, I. Craig Henderson, et al.. (1990). Esorubicin (4′-Deoxydoxorubicin, NSC 267469) in Advanced Breast Cancer. American Journal of Clinical Oncology. 13(3). 233–237. 2 indexed citations
11.
Budman, Daniel R., Ann H. Korzun, Joseph Aisner, et al.. (1990). A Feasibility Study of Intensive CAF as Outpatient Adjuvant Therapy for Stage II Breast Cancer in a Cooperative Group: CALGB 8443. Cancer Investigation. 8(6). 571–575. 7 indexed citations
12.
Weiss, Raymond B., et al.. (1989). Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: A cancer and leukemia group B study. The American Journal of Medicine. 87(5). 501–504. 68 indexed citations
13.
Mick, Rosemarie, Colin B. Begg, Karen H. Antman, Ann H. Korzun, & Emil Frei. (1989). Diverse prognosis in metastatic breast cancer: Who should be offered alternative initial therapies?. Breast Cancer Research and Treatment. 13(1). 33–38. 58 indexed citations
15.
Perry, Michael C., Carl G. Kardinal, Ann H. Korzun, et al.. (1987). Chemohormonal therapy in advanced carcinoma of the breast: Cancer and Leukemia Group B protocol 8081.. Journal of Clinical Oncology. 5(10). 1534–1545. 25 indexed citations
16.
Ellis, Mark, Raymond B. Weiss, Ann H. Korzun, et al.. (1986). Hyperglycemic Complications Associated with Adjuvant Chemotherapy of Breast Cancer A Cancer and Leukemia Group B (CALGB) Study. American Journal of Clinical Oncology. 9(6). 533–536. 12 indexed citations
17.
Korzun, Ann H., et al.. (1986). Comparative psychological disturbance in patients with pancreatic and gastric cancer. American Journal of Psychiatry. 143(8). 982–986. 124 indexed citations
18.
Wood, William C., Raymond B. Weiss, Douglass C. Tormey, et al.. (1985). A randomized trial of CMF versus CMFVP as adjuvant chemotherapy in women with node‐positive stage II breast cancer: A CALGB study. World Journal of Surgery. 9(5). 714–718. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026